250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Biotechnology VC Funds in France

A list of 50 VC funds that invest in Biotechnology startups based in France. We rank investors based on the number of investments they made in Biotechnology companies from France. We update this investor list every month.

Top 50 Biotechnology VC Funds in France

Investor Biotechnology France investments
Bpifrance 49
GO CAPITAL 26
Karista 25
Kurma Partners 24
Seventure Partners 22
Sofinnova Partners 21
Auriga Partners 19
Elaia 17
Idinvest Partners 16
Omnes Capital 15
Sofimac Investment Managers 12
AdBio partners 11
AQUITI Gestion 11
Inserm Transfert Initiative 9
Cap Innov'Est 9
Galia Gestion 8
Pontifax 7
Crédit Agricole 7
Sham Innovation Santé 7
Normandie Participations 6
M Capital Partners 6
Caisse d’Epargne 6
IRDI 6
Meusinvest (Noshaq) 6
BNP Paribas 6
Angels Santé 6
WiSEED 6
SOSV 6
Paca Investissement 6
CEA Investissement 5
IRDI SORIDEC Gestion 5
Crédit Mutuel Innovation 5
BNP Paribas Développement 5
Octalfa 5
Starquest Capital 5
Emertec 4
IXO Private Equity 4
Finovam Gestion 4
Casdin Capital 4
Aurinvest 4
Pertinence Invest 4
M Ventures 4
XAnge 4
Supernova Invest 4
ACG Management 4
Demeter 4
Truffle Capital 4
Societe Generale Asset Management 4
UI Investissement 4
AgFunder 4
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Bpifrance VC Fund · Maisons-alfort, Ile-de-France, France · 89 investments in the past 12 months
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Seed, Series A
  • France, United States, Switzerland
Portfolio highlights
  • RSight — RSight offers each customer, candidate, and partner with a one-of-a-kind and best-in-class recruitment, onboarding, and working experience. The company, above and beyond the current industry possibilities in providing enhanced service to recruiting organizations and individuals. The company is elevating the recruitment experience and interaction byproviding recruitment experience for each client, candidate, and partner.
  • Skynopy — Connecting satellites. As a service
  • C12 Quantum Electronics — C12 Quantum Electronics develop reliable quantum processors with carbon nanotubes. Its unique technology reduces drastically the error rate, making the platform a prime candidate for noisy intermediate-scale quantum applications. The Paris, Ile-de-France, France-based company was formed in 2019 by Pierre and Matthieu Desjardins.
GO CAPITAL VC Fund · Rennes, Bretagne, France · 11 investments in the past 12 months
GO CAPITAL is a management company approved by the AMF and a member of AFIC. It is based in Rennes, and manages more than 130 million of assets by investing primarily in western France in innovative companies with high growth potential.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Funding Round, Seed, Series A
  • France, Canada, Israel
Portfolio highlights
  • BIOPHTA — BIOPHTA has pioneered a new approach to eye care by creating a cutting-edge pharmaceutical platform that enables continuous drug delivery. Their non-invasive topical ocular inserts represent a significant advancement in the treatment of many ophthalmic disorders, providing superior long-term disease management.
  • Genevos — Genevos specializes in integrating hydrogen and fuel cell systems in the maritime industry.
  • Dealt — Dealt - La solution servicielle qui transforme votre activité retail et e-commerce
Montage, installation, configuration, entretien ou réparation… Dealt construit, implémente et gère votre offre de services en marque blanche, pour vous permettre de mieux accompagner vos clients et vous démarquer de la concurrence.Pour cela, Dealt met àdisposition des distributeurs une solution omnicanale complète, comprenant : - Les outils technologiques pour implémenter leur offre de services en marque blanche : plateforme de services, API, solution vendeur et back-office - Un catalogue de +300 services à tarifs négociés - Une communauté nationale de 10 000 professionnels certifiés - Un accompagnement total pour développer leur stratégie serviciellePassez d’un modèle de vendeur de produits à vendeur de solutions avec Dealt !Pourquoi adopter Dealt ? * +300 services disponibles * +10 000 Experts professionnels certifiés * +40 000 prestations réalisées * 4,86/5 de note moyenne * 94% de couverture nationaleCes enseignes nous font confiance : E.Leclerc, Mr. Bricolage, Botanic, Conforama, Monoprix, Casino, La Poste, Carmila…Dealt récompensé par l’écosystème retail français :- Lauréat des Trophées de l’Innovation E.Leclerc 2021, catégorie « Innovation Expérientielle »- Lauréat des Trophées 100% Retailtech LSA 2021, catégorie « Digitalisation du point de vente, expérience client et solution de paiement » - Elu start-up de l’année 2021 lors de l’événement « Connect Lille »Dealt est soutenu par le Groupe La Poste
Karista VC Fund · Paris, Ile-de-France, France · 6 investments in the past 12 months
Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.
Show more
Investment focus
  • Software, Biotechnology, Health Care
  • Seed, Series A, Series B
  • France, United States, Germany
Portfolio highlights
  • 10Lines — 10Lines is developing autonomous parking lot marking robots and technological solutions to significantly increase productivity in the industry of pavement marking. Our solutions are helping striping businesses do their work much more productively with a smaller environmental footprint.
  • BforeAI — Starting from patented technology developed in years of research, BforeAi is the prediction service that looks for newly registered or morphed domains, and score their maliciousness looking at metadata and links to other bad guys.
  • RebrAIn — RebrAIn makes it possible for individuals with severe Parkinson's or essential tremor disorder to get DBS treatment with precision targeting. Neurosurgeons can more accurately pinpoint the target location for electrode surgical insertion with the use of this SaaS service. Its innovative method predicts the treatment zone in each patient'sbrain using machine learning clinical patient data.
Kurma Partners VC Fund · Paris, Ile-de-France, France · 8 investments in the past 12 months
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more
Investment focus
  • Health Care, Biotechnology, Pharmaceutical
  • Series A, Series B, Seed
  • France, Switzerland, Spain
Portfolio highlights
  • Poppins — Mila merges music, technology, and neuroscience to reshape therapy into a musical experience. We create musical games for children based on neurologic music therapy methods. These games are designed to address learning dissabilities like dyslexia, providing a digital treatment at home and helping identify these conditions. Behind these games, weleverage data science and new technologies to interpret learning, language, and motor performance into a cognitive score. Our goal is to improve the process for patients receiving treatment and to reaching the vast undiagnosed majority.
  • Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
  • Vico Therapeutics — Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarilyaffecting girls that enable clients with providing therapy for it.Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Judith van Deutekom, and Gail Mandel and it is headquartered in Leiden, The Netherlands.
Seventure Partners VC Fund · Paris, Ile-de-France, France · 4 investments in the past 12 months
Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with€ 660 million under management as of December 31, 2016. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Series A, Series B, Funding Round
  • France, United States, Germany
Portfolio highlights
  • ID5 — ID5 provides a comprehensive suite of identification services designed to improve to improve addressability and measurement across all environments
  • Peptobiotics — We make agriculture more productive, humane and sustainable by promoting growth and protecting against pathogens using a new new type of antibiotic alternative that does not cause resistance. Our recombinant peptides are synthetic biology products manufactured in a patent pending precision fermentation process. We are launching a range of products across livestock and aquaculture in Asia.
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Sofinnova Partners VC Fund · Paris, Ile-de-France, France · 22 investments in the past 12 months
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom
Portfolio highlights
  • Cure51 — Cure51 mission is to create a database of cancer survivors to leverage their exceptional biological features and find new drugs to cure Cancer.
  • May Health — May Health is developing a modern treatment - Ovarian Rebalancing - designed to restore ovulation for people with polycystic ovary syndrome.
  • MISSION Therapeutics — Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas
Auriga Partners VC Fund · Paris, Ile-de-France, France
Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early stage funds specializing in Information Technology and Life Sciences.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Funding Round
  • France, United States, Switzerland
Portfolio highlights
  • Patrowl — Identify and harden your External Security Posture with the leader. Let us manage time-consuming tasks and focus on remediation
  • Exeliom — Exeliom is a clinical-stage biopharmaceutical company tackling the use of commensal bacteria as drugs. Their mission is to harness the therapeutic potential of gut microbiota to enable people to lead longer and healthier lives. They are committed to developing the next generation of probiotics: innovative microbial therapies.Exeliom develops anew class of medicines called Live Biotherapeutics based on their growing understanding of the central role of the microbiota in the immune system.The company was founded in 2016 and is headquartered in Dijon, France.
  • Vade Secure — Vade is a global leader in predictive email defense, protecting 1 billion inboxes worldwide. AI-based email security for Microsoft 365.
Elaia VC Fund · Paris, Ile-de-France, France · 23 investments in the past 12 months
Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Seed, Series A, Series B
  • France, United States, Spain
Portfolio highlights
  • Continuity — Continuity’s SaaS platform uses Open Data and AI to detect insurance contracts that are either outdated or invalid across four product lines including Professional Indemnity, Commercial Property, Construction Workers Insurance, and Directors & Officers Liability.
  • Descartes & Mauss — The first AI-powered SaaS Platform automating the Strategic Planning process.
  • Mitiga Solutions — Mitigating the risk from climate-driven perils to your business assets everywhere.
Idinvest Partners VC Fund · Paris, Ile-de-France, France
Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Series B, Series A, Funding Round
  • France, United States, Spain
Portfolio highlights
  • Corti — Corti offers a digital assistant, augmenting medics in improving patient outcomes and internal performance.
  • Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
  • Stilla Technologies — Stilla Technologies is taking digital PCR to a whole new level with a unique 6-color target detection capability
Omnes Capital VC Fund · Paris, Ile-de-France, France · 3 investments in the past 12 months
Omnes, "Powering Entrepreneurs" is a Leading private equity firm dedicated to energy transition and innovation.
Show more
Investment focus
  • Software, Biotechnology, Health Care
  • Series A, Funding Round, Series B
  • France, Germany, United States
Portfolio highlights
  • Planet A Foods — The chocolate revolution is here. 100% cocoa-free and unbelievably delicious. We call it QOA. You need to try it!
  • Quandela — Quandela is an expert in the fabrication of performing devices for the research in quantum photonics and quantum information. They fabricate unique solid-state sources of quantum light. These sources bring a new revolution in quantum technologies based on light.The company's single-photon source device combines photonics and semiconductorquantum dots for quantum communication, computation and sensing and permits to collect the emitted single-photons with exceptional efficiency at high rates, enabling researchers to strongly reduce the charge noise decoherence and assist in the emission of identical photons with fidelity close to unity, an essential requirement for the development of the most advanced quantum applications.
  • Unseenlabs — Unseenlabs designs and develops a spectrum surveillance payload which is designed to detect and track non-cooperative vessels wherever they happen to be in the world.
Sofimac Investment Managers VC Fund · Clermont-ferrand, Auvergne, France
Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)
Show more
Investment focus
  • Biotechnology, Health Care, Manufacturing
  • Funding Round, Seed, Series A
  • France, Italy, Austria
Portfolio highlights
  • Blue Valet — Blue Valet is a provider of valet parking-parking at airports and train stations.
  • Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
  • Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.
AdBio partners VC Fund · Paris, Ile-de-France, France · 2 investments in the past 12 months
AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Seed, Series A, Funding Round
  • France, Spain, Belgium
Portfolio highlights
  • Astraveus — Designing and building closed, automated, bioprocessing systems for the production of cell and gene therapies.
  • Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
  • Augustine Therapeutics — Augustine, Innovative therapies for neuromuscular and neurodegenerative diseases
AQUITI Gestion VC Fund · Bordeaux, Aquitaine, France · 2 investments in the past 12 months
Floated in 1998, thanks to the local authority "Conseil Régional d’Aquitaine" and the "Caisse des dépôts", our venture, growth and LBO funds (Aquitaine Amorçage, ACI, Aqui-Invest) now benefit from the support of public and private influential shareholders and sponsors.Up to now, AQUITI GESTION has invested in more than 200operations contributing to the creation and development of about 150 companies and thousands of jobs.Currently, ACI and Aqui-Invest manage a portfolio gathering 50 companies which revenues scale from 0 € (early stage) to 30 M€.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Funding Round, Seed, Series A
  • France, United States
Portfolio highlights
  • Dionymer — Dionymer is putting money into the circular economy by creating a method that uses microorganisms to convert industrial organic waste into biodegradable polyhydroxyalkanoates, or PHA, polymers.
  • Pony — Instant city bike hire
  • ALOGIA Groupe — ALOGIA Groupe offers preventive health responses to senior people at home through care management and innovative services.
Inserm Transfert Initiative VC Fund · Paris, Ile-de-France, France
Inserm Transfert Initiative is a seed stage life science vehicle currently managing about €4.2M for the financing of new biotech companies. Inserm Transfert Initiative is the new investment vehicle of INSERM in France.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Series A, Series B, Seed
  • France, Switzerland, United States
Portfolio highlights
  • Eyevensys — Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasiveprocedures. Eyevensys’ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability.They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.
  • VectivBio — We Are Ironwood
  • Aelis Farma — Aelis Farma is a pioneer in the development of signaling specific therapeutics that target GPCRs (and more specifically the CB1 receptor which is one of the most expressed GPCRs in the brain). GPCRs are the target of most therapeutic drugs. This family of receptors has the characteristics to activate several and often opposing signaling pathways.Unfortunately, most of the drugs acting on GPCRs either block or stimulate the entire signaling activity of the receptor resulting in unwanted and sometimes unacceptable side effects.
Cap Innov'Est VC Fund · Illkirch-graffenstaden, Alsace, France
Cap Innov’Est is a 36M€ tri-regional fund dedicated to investments in young innovative start-ups. Cap Innov’Est was launched in July 2014 and has already invested in 13 start-ups. Cap Innov’Est is supported by Fonds National d’Amorçage, the 3 Regions Alsace, Bourgogne and Franche-Comté, SAFIDI, caisses d’épargne d’Alsace etBourgogne/Franche-Comté, BNP Paribas et CIFC
Show more
Investment focus
  • Biotechnology, Pharmaceutical, Health Care
  • Seed, Series A, Funding Round
  • France, United States
Portfolio highlights
  • VistaCare — "Making Difficult Wounds Easy" : VistaCare is a Breakthrough and non-invasive Medical Device designed for treatment during the critical phases of the wound.
  • Opencell Software — Increase recurring revenue. Opencell's platform simplifies launch, scales with your business, and streamlines billing. Optimize sales cycles, improve customer experience, and gain valuable revenue insights. Start today!
  • Rhythm Diagnostic Systems — Many of our team have worked together on different projects and in different companies over the last 30-plus years. We are experienced technology, medical, health care and biotech professionals, with long, successful histories in Silicon Valley and elsewhere.
Galia Gestion VC Fund · Bordeaux, Aquitaine, France
Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.
Show more
Investment focus
  • Software, Manufacturing, Biotechnology
  • Funding Round, Series A, Seed
  • France, United States
Portfolio highlights
  • Wizaly — Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations.
  • Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
  • Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
Pontifax VC Fund · Herzliya, Tel Aviv, Israel · 3 investments in the past 12 months
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, Israel, France
Portfolio highlights
  • Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
  • Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
  • AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
Crédit Agricole VC Fund · Paris, Ile-de-France, France · 7 investments in the past 12 months
Credit Agricole is a banking corporation with focuses on corporate and investment banking, retail banking, and savings management. Crédit Agricole Group is a responsible, helpful bank serving 49 million customers, 7.4 million mutual shareholders, and 1.2 million shareholders. Crédit Agricole Group supports its customers in their plans and projectsin France and around the world, through its operations in all segments of the market including insurance, real estate, payment systems, asset management, leasing and factoring, consumer finance, and corporate and investment banking. Crédit Agricole also stands out for its dynamic, innovative corporate social responsibility policy serving the economy. This policy is based on a pragmatic approach that permeates throughout the entire Group and engages all its employees. Its recent inclusion in the Vigeo-NYSE Euronext extra-financial indices is recognition of this engagement.
Show more
Investment focus
  • Software, Manufacturing, Health Care
  • Funding Round, Seed, Debt Financing
  • France, United States, Italy
Portfolio highlights
  • Loop Dee Science — Loop Dee Science is a DNA startup that makes molecular biology diagnostics. They develop and manufacture field genetic analysis kits for the detection of pathogen DNA and RNA. Their automatic field analysis device is a multi-spectral analysis device that provides local output and can also be connected via USB or Bluetooth.
  • Technique Solaire — Technique Solaire specializes in the distribution of photovoltaic energy for individuals and businesses as corant from solar panels.
  • Arkeon Energy Systems — Arkeon Energy Systems develops hermodynamic cycles and thermal stages to meet heating, air conditioning, and electricity needs.
Sham Innovation Santé VC Fund · Lyon, Rhone-Alpes, France
Sham Innovation Sante is an innovation capital vehicle controlled and held by Sham, a mutual insurer specialized in risk management for health care, social welfare and community health organizations. Advised by Turenne Capital, Sham Innovation Sante's mission is to support innovative businesses in the health care sector through the growth anddevelopment phases of their life cycle.
Show more
Investment focus
  • Biotechnology, Medical Device, Medical
  • Series B, Series A, Funding Round
  • France
Portfolio highlights
  • Cairdac — Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation.
  • Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.
  • Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
Normandie Participations VC Fund · Colombelles, Basse-Normandie, France
Normandie Participations is a venture capital fund that co-invests in companies based in Normandy. It invests through equity and quasi-equity in small and medium-sized enterprises. The firm was founded in 2016 and is based in Colombelles, France.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Funding Round, Seed, Series A
  • France
Portfolio highlights
  • Sinay — Use the full potential of your data with intelligent solutions. Become more efficient on a daily basis and reduce your environmental impact.
  • Loop Dee Science — Loop Dee Science is a DNA startup that makes molecular biology diagnostics. They develop and manufacture field genetic analysis kits for the detection of pathogen DNA and RNA. Their automatic field analysis device is a multi-spectral analysis device that provides local output and can also be connected via USB or Bluetooth.
  • Aurora Cold Plasma Sterilisation — Aurora Cold Plasma Sterilisation provides low temperature plasma sterilator for medical and research purposes.
M Capital Partners VC Fund · Toulouse, Midi-Pyrenees, France
M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.
Show more
Investment focus
  • Health Care, Food and Beverage, Software
  • Funding Round, Seed, Series A
  • France, United States, Canada
Portfolio highlights
  • Ellona — Ellona offers advanced solutions for odor control and air quality monitoring, providing customized industrial applications. Discover our innovative products and services.
  • Olino — Olino is the insurance for tomorrow's SME. A digital service, a turnkey solution tailored to VSBs and SMEs, meeting all insurance needs.
  • Ascendance Flight Technologies — Sustainable flight solutions for today & tomorrow... because cleaner aviation can't wait. With Ascendance, Fly quieter, cleaner, further.
Caisse d’Epargne VC Fund · Paris, Ile-de-France, France · 3 investments in the past 12 months
Caisse d’Epargne is a cooperative bank that supports all economic players. It shares its values ​​of social responsibility and humanism with its member customers. It is committed to the heart of the regions, the 15 regional savings banks are involved on a daily basis in their clients' projects and provide them with tailor-made solutions.Ithas now had 4.8 million members and 20.6 million customers, managed by 4,182 bank branches and the My Online Banker branch.It was created in 1818 and is headquartered in Paris, France.
Show more
Investment focus
  • Health Care, Biotechnology, Manufacturing
  • Funding Round, Debt Financing, Seed
  • France
Portfolio highlights
  • ADEMUS — ADEMUS manufactures high-end electric motorcycles combined with craftsmanship, new technologies integrating with several innovations.
  • BiOceanOr — BiOceanOr harnessed the power of Marine Biology and AI to deliver bio-guided services that optimize fish welfare and fish growth, while supporting aquaculture sustainability standards
  • Oncodesign — Biotech specialized in precision medicine, our mission is to bring innovative therapeutic and diagnostic solutions to treat resistant and metastasis cancer.
IRDI VC Fund · Toulouse, Midi-Pyrenees, France
IRDI Gestion is a private equity and venture capital institution.
Show more
Investment focus
  • Health Care, Software, Biotechnology
  • Funding Round, Series A, Series B
  • France
Portfolio highlights
  • REEV — REEV motorizes medical orthoses to help millions of people affected by gait disorders to walk, stand, sit and climb stairs with greater ease every day.
  • Micropep Technologies — Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control.
  • Ascendance Flight Technologies — Sustainable flight solutions for today & tomorrow... because cleaner aviation can't wait. With Ascendance, Fly quieter, cleaner, further.
Meusinvest (Noshaq) VC Fund · Liège, Liege, Belgium · 8 investments in the past 12 months
Noshaq offers financial services to help businesses develop.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Funding Round
  • Belgium, France, Germany
Portfolio highlights
  • Samabriva — Biotechnology company that has developed an automated, proprietary bioproduction system available to companies who want to produce high-value molecules.
  • Raw Stadia — Raw Stadia is a sports technology company that specializes in surface player interactions.
  • HEPHAISTOS-Pharma — Hephaistos Pharma is a developing weapons firm. They provide services for oncology, immunotherapy, and cancer. An online inquiry form is available on the company's website.
BNP Paribas VC Fund · Paris, Ile-de-France, France · 10 investments in the past 12 months
BNP Paribas provides banking, financing, investment, savings, and protection solutions. Their investment services include businesses that provide savings, investment, and protection services. They provide financing and investment services to retail customers, associations, businesses, and corporations.
Show more
Investment focus
  • Information Technology, Financial Services, Software
  • Debt Financing, Funding Round, Post-IPO Debt
  • France, United Kingdom, United States
Portfolio highlights
  • Safehold — Safehold Inc. is a leading provider of modern ground leases, enabling property owners to unlock the embedded value of their land.
  • Merci Julie — Merci Julie is a company that supports seniors to age peacefully at home and in complete safety.
  • United Fintech — Digital transformation in finance. Uniting Fintechs and Financial Institutions on a single platform, offering innovative solutions within capital markets.
Angels Santé VC Fund · Puteaux, Ile-de-France, France · 2 investments in the past 12 months
Angels Santé is a networking site for investors and companies in the health sector.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Seed, Funding Round, Angel
  • France, India, United States
Portfolio highlights
  • Abcely — Abcely is a biotech firm that is working on a novel anti-cancer medication.
  • Odimma — Empowering personalized immunotherapy to treat cancer
  • SeaBeLife — SeaBeLife is a biotechnology company that develops a range of drug candidates intended to block regulated necrosis (or regulated cell death of cells), from a family of patented molecules.
WiSEED VC Fund · Toulouse, Midi-Pyrenees, France
Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.
Show more
Investment focus
  • Software, Manufacturing, Biotechnology
  • Seed, Funding Round, Equity Crowdfunding
  • France
Portfolio highlights
  • Dianosic — Dianosic was founded in 2017 and develops innovative solutions in the field of ENT (Ear, Nose & Throat), a $50 billion, double digit growth, and still largely underserved market. Our startup operates right at the frontier between Medtech and Biotech, as we see tremendous opportunities for drug-device combinations in this specialty. The projectoriginates from the ENT Department from the University Hospital of Strasbourg, where unmet clinical needs have been identified. Our main focus areas are Chronic Rhinitis, Chronic Sinusitis and intranasal bleeding (Epistaxis). Noteworthy, Dianosic has a strong French and German footprint in R&D and manufacturing.Dianosic’s strategic goal is to establish new standards of care in Chronic Rhinitis and Chronic Sinusitis with its drug-eluting Active Resorbable Scaffold (ARIS). This drug-device combination ARIS platform, developed with world renowned resorbable polymers experts, has the potential to establish new treatment paradigms. Moreover, our ARIS platform creates immense opportunities to create other verticals, especially in the field of chronic migraine and facial pain.Beside this, Dianosic commercialize an Asymmetric Intranasal inflatable solution (CAVI-T) for the treatment of intranasal bleeding, a widespread condition in ENT that affects 10% of the population. This CE marked and FDA registered technology addresses a clear unmet need and demonstrated our ability not only to develop a differentiated technology in record time, but also to successfully transition from R&D to Sales. We are currently present in relevant markets in EU and paving the way to launch in the U.S. in the mid term. Noteworthy, since our main call point is the ENT, CAVI-T prepares the ground for our upcoming ARIS platform.
  • VistaCare — "Making Difficult Wounds Easy" : VistaCare is a Breakthrough and non-invasive Medical Device designed for treatment during the critical phases of the wound.
  • BiPER Therapeutics — BiPER Therapeutics : First-In-Class Therapeutics to Treat Cancer. Biotech company founded in 2021 to develop and commercialize novel therapeutics.
SOSV VC Fund · Princeton, New Jersey, United States · 95 investments in the past 12 months
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Convertible Note, Pre-Seed
  • United States, India, United Kingdom
Portfolio highlights
  • NovoNutrients — NovoNutrients is working to turn waste CO2 into high-value, low-cost proteins and additives for food and feed by developing proprietary microbes and advanced gas fermentation systems.
  • OncoPrecision — We're developing personalized assays to determine the most suitable medication for cancer therapy at the patient level. Through our proprietary Drug Activity and Resistance Test, oncologists will be able to make data-driven decisions regarding cancer therapy selection based on patient-derived samples. Our goal is to democratize access toPrecision Oncology and improve cancer patients' lives.
  • Sodex Innovations — Sodex Innovations is a company which is specialized in developing assistance-systems and automating-kits for excavators
Paca Investissement VC Fund · Paris, Ile-de-France, France
Paca Investissement is specializes in investing in startups and developmental stages. The fund invests in the Provence-Alpes-Côte d'Azur (PACA) region.
Show more
Investment focus
  • Software, Internet, Manufacturing
  • Seed, Funding Round, Series A
  • France
Portfolio highlights
  • GANGZ — I found a great domain name for sale on Dan.com. Check it out!
  • SailEazy — The SailEazy community offers all sailing enthusiasts the choice of freedom. A shared professional fleet, bases between the Atlantic and the Mediterranean ... discover a disruptive and innovative way of navigation. Throughout the year, 7 days / 7 and 24 hours a day, you can book and discover the high-performance sailboats of a professionalfleet, entirely managed by SailEazy. Subscriber, or punctual browser, autonomous or not, you have the choice. You freely determine your niche of reservation, without constraint time or duration, you choose your base of departure and your sailboat, according to your program (short exit, cruise, regatta, coastal, wide ...). Hourly pricing includes a 360 ° service keychain beyond the cost of the lease, including insurance, fuel, cleaning and equipment. Compulsive veiled, expert or contemplative, all members of the community have their way of navigating.
  • C4Diagnostics — C4Diagnostics developed a fast, reliable detection of microorganisms. Our Click-chemistry technology is at the core of our portfolio of diagnostic tests.
CEA Investissement VC Fund · Paris, Ile-de-France, France
CEA Investissement (SA), founded (as CEA Valorisation) in 1999, is a subsidiary of the CEA, a major player in technological research, development and innovation. The central mission of CEA Valorisation is to create economic value based on technological innovations. To fulfill this mission, they have developed two main activities: Investmentin seed capital in innovative start-ups / start-ups active in the technology areas of CEA. The Licensing of advising companies and public laboratories of innovation in creative strategy development and marketing rights to patent or know-how belonging to the CEA, other research organizations or innovative companies. In addition, CEA contributes to the financing of national investment in seed technology (activity "Fund of Funds"), this activity is developed through particular Emertec management and funds managed by this company (FCPR Emertec 2 Emertec Energy and Environment), the FCPR managed by ACE Security Management SA, an investment company in seed priming Minatec SAS. Their areas of technological expertise are mainly micro-and nanotechnology, health technologies, the New Technologies for Information and Communication (NTIC), advanced materials and technologies for energy.
Show more
Investment focus
  • Biotechnology, Manufacturing, Software
  • Seed, Series A, Funding Round
  • France, Canada, United States
Portfolio highlights
  • ISORG — Complete solutions provider of self-manufactured hardware & software for fingerprint matching on large area & smartphones. Higher security with multiple fingers authentications.
  • EnobraQ — EnobraQ is a start-up created in 2015, from a pre-competitive research project supported by Toulouse White Biotechnology (TWB). Concerned with ecological and economic considerations, EnobraQ develops breakthrough technologies that use CO2 and target markets as diverse as nutrition, agri-food, cosmetics, pharmacology and bioplastics.
  • ISYBOT — ISYBOT is a designer and manufacturer of collaborative robots or "Cobots", that is to say, robots working in collaboration with workers. Its cobots work with workers and make it possible to: - reduce the arduousness of workstations - multiply their productivity - enhance manual workstations ISYBOT is based on a breakthrough technicalinnovation, resulting from 15 years of R&D carried out within CEA LIST .
IRDI SORIDEC Gestion VC Fund · 6 investments in the past 12 months
IRDI SORIDEC Gestion
Show more
Investment focus
  • Biotechnology, Information Technology, Health Care
  • Funding Round, Seed, Series A
  • France
Portfolio highlights
  • SCOP3 — SCOP3 is a platform that gives new life to professional equipment. SCOP3 was founded in 2021 and was headquartered in Montpellier, France.
  • TurnK — TurnK est le 1er Groupe de Service 100% No Code. Notre métier ? Concevoir, paramétrer et connecter entre eux vos outils métiers sans développement informatique. TurnK propose 4 services : #1 Web Design : Refonte de site vitrine & Ecommerce #2 Integration : Intégration et parametrage de votre CRM, ERP, outil de ticketing, marketing #3 AppBuilder: Création de votre outil métier personnalisé #4 Placement : Internalisation de compétence sur votre stack interne
  • Infinite Orbits — Infinite Orbits is a company with a vision to provide reliable, turnkey in - orbit services to satellite operators all over the world.
Crédit Mutuel Innovation VC Fund · Paris, Ile-de-France, France · 5 investments in the past 12 months
Crédit Mutuel Innovation is the evergreen venture capital entity of Crédit Mutuel Equity (€3.5 billion in capital). We invest €1-20M in life science, digital and deeptech companies from seed to growth stages.We help bold and ambitious entrepreneurs to develop their strong growth potential with our worldwide enterprise ecosystem (our 350+portfolio companies, our abroad subsidiaries, 150+ largest global corporates and the best-in-class experts). Because it takes more than 5 years to build a Unicorn, we invest our own equity and ensure durable partnerships with visionary leaders.Today, the 350 companies in which we have invested generate a cumulative annual turnover of €50bn and create more than 250,000 jobs.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Funding Round, Series A, Series B
  • France, United States, Canada
Portfolio highlights
  • Quandela — Quandela is an expert in the fabrication of performing devices for the research in quantum photonics and quantum information. They fabricate unique solid-state sources of quantum light. These sources bring a new revolution in quantum technologies based on light.The company's single-photon source device combines photonics and semiconductorquantum dots for quantum communication, computation and sensing and permits to collect the emitted single-photons with exceptional efficiency at high rates, enabling researchers to strongly reduce the charge noise decoherence and assist in the emission of identical photons with fidelity close to unity, an essential requirement for the development of the most advanced quantum applications.
  • HarfangLab — HarfangLab develops a hunting software to boost detection and neutralization of cyberattacks against companies endpoints. They plug their platform to third-party cybersecurity solutions to enhance visibility on your system. Their specialists have led many operations of defensive and offensive cyberwarfare for ANSSI (the French National Agency forthe Security of Information Systems), the French ministry of Defense and major cybersecurity companies.
  • Latitude — Venture Orbital Systems provides a tailor-made service for NanoSat & CubeSat operators.
BNP Paribas Développement VC Fund · Paris, Ile-de-France, France · 10 investments in the past 12 months
BNP Paribas Développement is the investment arm of BNP Paribas that specializes in SME development. It specializes in second stage, mezzanine, bridge, acquisition, leveraged buyouts, management buyouts, recapitalization, special situations, and privatizations transactions.The firm considers investments in manufacturing, service industries,medicine, electronics, energy, chemistry, new materials, industrial automations, industrial goods and services, transportation, consumer goods, commerce and distribution, buildings and public works, wholesale retail, biotechnology, telecommunications, and information technology sectors.BNP Paribas Développement was established in 1988 and is based in Paris, France.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Series A, Seed
  • France, Germany, The Netherlands
Portfolio highlights
  • Dipeeo — Dipeeo, a BtoB SaaS automation platform, combines GDPR expertise with a BPO platform to manage clients' compliance, it simplifies GDPR compliance, offering personalized support, strengthening businesses and boosting confidence.
  • ANOZR WAY — Human risk management platform for monitoring, alerting and recommending remediation of employee and manager vulnerabilities.
  • C12 Quantum Electronics — C12 Quantum Electronics develop reliable quantum processors with carbon nanotubes. Its unique technology reduces drastically the error rate, making the platform a prime candidate for noisy intermediate-scale quantum applications. The Paris, Ile-de-France, France-based company was formed in 2019 by Pierre and Matthieu Desjardins.
Octalfa VC Fund · Écully, Rhone-Alpes, France
Octalfa is a France-based venture capital firm that offers a range of financial services.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Funding Round, Seed, Series A
  • France
Portfolio highlights
  • Mathym — Mathym - a nanotechnology company dedicated to the development, manufacturing and commercialization of nanomaterials and nanodispersions.
  • Amolyt Pharma — We are building on our team's established expertise in therapeutic peptides to deliver life-changing treatments to patients suffering from rare endocrine and metabolic diseases.
  • ORPHELIA Pharma — ORPHELIA Pharma is a French pharmaceutical company dedicated to the development and marketing of pediatric drugs for oncology and CNS diseases. ORPHELIA’s mission is to significantly improve essential medicines administered to children through the development of efficient, reliable and safe drugs with child-friendly formulations. We focus ondeveloping optimized formulations for the pediatric population of approved drugs as well as obtaining the approval for existing drugs in new pediatric orphan indications.
Starquest Capital VC Fund · Paris, Ile-de-France, France · 2 investments in the past 12 months
High Tech, Low Carbon: crafting tomorrow, today. We finance innovation to make tomorrow happen today. Starquest is a Montefiore Company.
Show more
Investment focus
  • Software, Manufacturing, Information Technology
  • Seed, Funding Round, Series A
  • France, Singapore, The Netherlands
Portfolio highlights
  • Cailabs — Cailabs is a French deep tech company, based in Rennes, which designs, produces and sells photonic solutions to fully exploit the industrial potential opened up by the shaping of light.Cailabs develops and produces a unique range of optical components based on its know-how and its patented technological innovations, in particular Multi-PlaneLight Conversion (MPLC).
  • Hello Watt — Hello Watt is a digital enthusiasts and developers who help you reduce your energy bills while improving your comfort.
  • Caeli Énergie — Caeli Énergie develops and manufactures next-generation air conditioners with great energy efficiency and a minimal carbon impact.
Emertec VC Fund · Grenoble, Rhone-Alpes, France
EMERTEC’s experienced investment team has developed proven track record and has been able to develop close ties with major industrial players, many of them also being investors in their funds.These close ties are extremely valuable as to understand medium and long-term requirements of major order placers and high-level commercial opportunities.This brings visibility and confidence for entrepreneurs as well as for its investors.Their objective is to create value by turning ground-breaking technological innovations into commercial and financial successful companies.
Show more
Investment focus
  • Biotechnology, Energy, Software
  • Series A, Funding Round, Series B
  • France, Canada, United States
Portfolio highlights
  • Ynsect — We are the world leader in insect ingredient production for animals, people, and plants. Our goal? To make the way we eat more nutritious and sustainable.
  • eLichens — eLichens is a sensor tech company that takes sensor technology to the next level. Its mission is to empower people, companies, and government agencies to improve air quality, both indoor and outdoor.
  • Osmia — Osmia SAS provides crop pollination services to improve yield and quality of agricultural production. Osmia intervenes in the context of specific problems on entomophilous or anemophilic pollination. Methodological approach and experience enables the company to find relevant solutions. It offers pollination studies and services for pre-base, baseor multiplication seeds. It also offers simple and efficient pollination services for arboriculture and optimize the yields and the quality of the productions of fruit trees.Osmia SAS was founded on 2014 and is headquartered in France.
IXO Private Equity VC Fund · Toulouse, Midi-Pyrenees, France · 7 investments in the past 12 months
The private equity fund focused on adding high value.IXO Private Equity is a private equity management company recognized, approved and authorized by the Financial Market Authorities (AMF) operating under the number GP03018.IXO Private Equity is the most important independent regional private equity General Partner in France.The companymanages French General Private Equity Investment Funds (known in France as F.C.P.R.), Local Private Equity Investment Fund (known in France as F.I.P.), and Private Equity Investment Funds for Innovation (F.C.P.I.) to meet the equity needs for the best companies in Western and Southern France.
Show more
Investment focus
  • Health Care, Manufacturing, Biotechnology
  • Private Equity, Funding Round, Series A
  • France, United States, Canada
Portfolio highlights
  • F-Reg — F-Reg autonomous and intelligent hydraulic valves are designed to regulate and control flow patterns in sanitation networks. F-Reg sells solutions for regulating flow in networks (rainwater or wastewater) that rely on a patented valve that smooths out peaks in wet weather. The F-Reg device is self-contained and does not require power.
  • Indy — Indy offers end-to-end and advanced AI-powered accounting software. Indy is an accounting robot that aims to automate the accounting of freelancers and professionals. It is an accounting robot for the liberal professions. It automates the management of accounting, recovers bank entries to turn them into accounting lines, and sends tax returnsdirectly to an AGM.It was founded in 2016 as Georges by Côme Fouques, Pablo Larvor, Romain Koenig, and Adrien Plat to simplify independent accounting, which is certainly simple but repetitive and time-consuming.
  • Farmitoo — Farmitoo is an online purchase of farm equipment directly from manufacturers.
Finovam Gestion VC Fund · Villeneuve, Provence-Alpes-Cote d'Azur, France · 4 investments in the past 12 months
Finovam Gestion is an investment company approved by the AMF which takes minority stakes in innovative SMEs with high growth potential.The company, which manages €50M, invests in companies that have developed innovative offers in the following target sectors: Information and Communication Technology, Health and Biotechnologies, Agro-resources andEcotechnologies.Finovam Gestion has built solid relationships with the ecosystem of entrepreneurship (Industrials, Poles of Competitiveness, Incubators, Accelerators, Universities, and Research Centers) in all the sectors that we target in order to be able to source and do emerge the best companies.Among our investors (LPs), we can count BPI France, manufacturers (ADEO, LESAFFRE, TEREOS), banks (BNP Paribas, Caisse d´Epargne, Crédit Agricole) and the Haut de France and Grand-Est regions.
Show more
Investment focus
  • Information Technology, Software, Medical Device
  • Seed, Funding Round, Series A
  • France, United States
Portfolio highlights
  • Nijta — Nijta provides a robust and secure speech anonymization solution to contact centers to access high-quality data for voice analytics.
  • Selvitys — Selvitys is a fully automated method for designing, delivering, and analyzing online surveys.
  • Osiris agriculture — Osiris desires to make agriculture more sustainable while also assisting farmers in living more peacefully. The business is working on a robot that will assist farmers in growing potatoes, sugar beets, and field crops. This four-wheeled robot will be able to automate and improve functions such as watering, fertilizing, weeding, and crop protection.
Casdin Capital VC Fund · New York, New York, United States · 5 investments in the past 12 months
Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry. It manages a long-short equity fund and makes investments in early-stage to late-stage private investments. Casdin was launched in 2012 by founder and CIO Eli Casdin and as of October 2020 has approximately $2.2 billion in assets undermanagement.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series B, Series A, Series C
  • United States, France, China
Portfolio highlights
  • Remix Therapeutics — Remix Therapeutics is a biotechnology company that develops novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways.
  • Century Therapeutics — Century Therapeutics is on a mission to develop innovative allogeneic, iPSC-derived NK and T cell therapies that are more effective, tolerable, accessible, and affordable versus existing cells therapies.
  • BridgeBio Oncology Therapeutics — BridgeBio Oncology Therapeutics operates as a biopharmaceutical company.
Aurinvest VC Fund · Paris, Ile-de-France, France
Aurinvest is a venture capital fund it is managed and primarily funded by more than fifty entrepreneurs and business leaders, alongside with institutional investors. The company's goal is to invest in high growth companies or ventures which are on the edge of an exciting journey. It accompanies the founders in successfully carrying out theirplan. With this purpose, each holding is coached by two experienced professionals who stay in close contact with companies' management and who interface with Aurinvest's network.
Show more
Investment focus
  • Software, Biotechnology, E-Commerce
  • Funding Round, Series B, Series A
  • France, United States, Belgium
Portfolio highlights
  • Famoco — Famoco provides an Enterprise Mobility Management (EMM) solution with a range of secure, remotely managed Android devices. Famoco offers...
  • PathoQuest — PathoQuest provides biosafety assays based on next-generation sequencing (NGS) for biologics quality testing. GMP biotesting for biopharmaceuticals. Learn more.
  • Evercontact — Let Evercontact connect the dots in your life by turning your emails into an always-updated address book!
Pertinence Invest VC Fund · Villeurbanne, Rhone-Alpes, France
Pertinence Invest is an investment Firm that works with tech start ups.
Show more
Investment focus
  • Biotechnology, Medical, CRM
  • Seed
  • France
Portfolio highlights
  • BIOMAE — BIOMAE provides biomonitoring tools to measure contamination and toxicity of aquatic environments. The company presents tools for measuring and monitoring the quality of aquatic environments from markers of effects on a pollutant invertebrate transplanted directly into the environment. The biomonitoring tools come from years of research, making itpossible to analyze the bioavailability of the contaminants and the degree of toxicity, directly in the medium. The company operates a methodological breakthrough to identify the issue of diagnosis for environmental quality monitoring.BIOMAE was founded on 2014 and is based in Gaillard, France.
  • Skinjay — Skinjay presents you with an opportunity to combine a priceless moment of well-being with a daily ritual: SHOWERING.Thanks to a concept that offers an innovative and particularly effective method for diffusing essential oils into shower water, Skinjay helps you benefit from the positive effects of Aromatherapy and Aromachology directly on yourbody and through inhalation, all the while you enjoy an intense moment of well-being in the shower.Adopt Skinjay, install the Module in your shower very easily, and choose the essential oil shower capsules depending on your wishes and needs on the day.The Aromachology capsules from the ODYSSEY collection will stimulate your senses and take you on an intense emotional journey to the heart of your memories, while the Aromatherapy capsules from the MISSION collection.Will ease the minor ailments of your daily life thanks to the recognised beneficial qualities of essential oils.
  • Mablink Bioscience — Mablink Bioscience is a biotechnology company specialized in the development of a new class of cancer drugs, called Antibody Drug Conjugate (ADC).
M Ventures VC Fund · Amsterdam, Noord-Holland, The Netherlands · 14 investments in the past 12 months
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, Switzerland, United Kingdom
Portfolio highlights
  • LabGenius — Finding the next generation of drugs with machine learning, synthetic biology and laboratory automation
  • Outrun TX — Outrun TX develops a platform for the identification of therapeutics that selectively target the protein degradation pathway.
  • Theolytics — Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing aninternal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.
XAnge VC Fund · Paris, Ile-de-France, France · 6 investments in the past 12 months
For 20 years, XAnge has been a key venture capital fund in Europe. With 70 startups in its portfolio, XAnge invests early in innovative tech companies.
Show more
Investment focus
  • Software, SaaS, Information Technology
  • Series A, Seed, Series B
  • France, Germany, Belgium
Portfolio highlights
  • airfocus — airfocus is the first modular product management software: Manage and communicate your product strategy, prioritize your roadmap, and solve the right problems.
  • Estuaire — Estuaire It seeks to strengthen the aviation sector by lessening its negative environmental effects. Their data firm is investigating all aspects of aviation pollution, such as CO2 emissions, NOx emissions, contrails, and aircraft production. Actionable indicators are provided to airlines, lessors, and carbon calculators to lessen the impact of airtravel.
  • Sirona Technologies — Pioneering direct air capture (DAC) technology with a focus on speed, scalability and a low capex design.
Supernova Invest VC Fund · Paris, Ile-de-France, France · 6 investments in the past 12 months
we believe that top scientists and ambitious entrepreneurs can build a world where cutting-edge technologies shape the next generation of industry leaders.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Series A, Funding Round, Seed
  • France, Switzerland, United States
Portfolio highlights
  • Unseenlabs — Unseenlabs designs and develops a spectrum surveillance payload which is designed to detect and track non-cooperative vessels wherever they happen to be in the world.
  • SEEDERAL Technologies — Seederal Technologies produces electric tractor.
  • Cambridge Mechatronics — Cambridge Mechatronics (CML) is a high technology design and engineering company based in Cambridge, UK. We specialise in pioneering and developing cutting-edge mechatronic platform technology from concept to mass production. We achieve this through technology licensing or partnerships with global manufacturing corporations. Our intellectualproperty portfolio consists of over 100 granted patents that we can exploit.
ACG Management VC Fund · Marseille, Provence-Alpes-Cote d'Azur, France
Smalt Capital anciennement ACG Management, est un acteur majeur depuis plus de 20 ans
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Funding Round, Seed, Series A
  • France, Madagascar
Portfolio highlights
  • Kamp'n — Partenaire de croissance Facebook Ads & Google Ads
  • Little Cigogne — Little Cigogne is reinvents the shopping experience for children.
  • My Coach Football — My Coach Football allows you to manage and organize the daily operations of your football team, day after day, season after season. Designed to answer amateur and professional coaches’ needs, the platform centralizes all of your squad’s information and allows to gain time and efficiency. In a single click, you can manage players and their personalinformation, the preparation of training and games, but also individual and collective statistics. Season after season, you keep all those data and hence enjoy an optimum tracking of your team’s progression.
Demeter VC Fund · Paris, Ile-de-France, France · 11 investments in the past 12 months
Demeter is a major player in venture capital and private equity for the energy and ecological transition. They invest from 500 K€ to 30 M€ to support companies at all stages of their development: innovative startups, high growth SMEs and infrastructure projects.
Show more
Investment focus
  • Manufacturing, Software, Renewable Energy
  • Funding Round, Seed, Series A
  • France, Germany, Slovenia
Portfolio highlights
  • GIREVE — GIREVE is contributing to the emergence of an open market for electric mobility services that accompanies the development of this type of soft mobility.
  • Onafis — Onafis is a company that provides digital solutions for tracking each stage of winemaking in real time on wines, beers, and spirits, adaptable to different types of containers.
  • Viti-Tunnel — Viti-Tunnel is a farm-tech company that provides innovative retractable tunnel devices for automatically sheltering rows of vines during rain, hail, frost, and weather damage.
Truffle Capital VC Fund · Paris, Ile-de-France, France · 2 investments in the past 12 months
Business Builders, Truffle
Show more
Investment focus
  • Biotechnology, Financial Services, Health Care
  • Funding Round, Series A, Series B
  • France, United States, Belgium
Portfolio highlights
  • Obat — Obat is a saas solution provider that uses software for contractors and self-employed for invoicing.
  • Levenue — Levenue is a platform that helps recurring revenue businesses to get funded without dilution of shares
  • MoneyTrack — MoneyTrack is a global, decentralized blockchain platform for Directed Money.
Societe Generale Asset Management VC Fund · Paris, Ile-de-France, France
SGAM AI is a leading institutional player in Alternative Investment Management. SGAM AI successfully mixes the cultures of asset management and capital markets. They are client driven and institutional, like an asset manager. Their approach of each market is entrepreneurial and financial, like an investment bank. They offer the widest coverage ofAlternative Investment classes. Their size and profitability allow long term investments and credibility. They have the ability to offer solutions, not only products. SG Group's strengths are brought to the Alternative Investment's industry. They benefit from SG Group's long term commitment in Alternative Investments. They use the processes ans resources of SGAM Group (rated M2 by Fitch).
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Series B, Funding Round, Series A
  • France, United States, Germany
Portfolio highlights
  • Augure — Improve your brand performance with Launchmetrics' leading software solutions for fashion, lifestyle and beauty brands
  • Force-A — FORCE-A designs, produces, and sells optical sensors for the assessment of physiological and health status of crops. It offers crop sensors for nondestructive assessment of leaf polyphenolics. The company also provides multiparameter noncontact sensors-based on leaves or fruits, and berries autofluorescence measurements. Its multiparameternoncontact sensor provides inputs for decision support systems for a range of crops, including fertilisation needs, weed infestation, crop diseases, and crop yield and quality forecast. The company was founded in 2004 and is based in Orsay, France.
  • METRIXWARE — Metrixware has, since 1995, been providing software maintenance & quality management solutions to CIOs and IT professionals through its System Code range of application management tools. The company provides global organizations with information, indicators and diagnostic to streamline decision making and implement best practice and compliancestandards.
UI Investissement VC Fund · Paris, Ile-de-France, France · 21 investments in the past 12 months
Since 1967, the UI brand embodies a partnership with companies. Actor of the economy, UI has accompanied more than 120 SMEs over the last fifteen years, investing more than 550m € and giving substance to their development projects. Combining experience and corporate culture, UI has established itself as an involved and independent partner, able tocount on its shareholder leaders to favor, independently, the sustainable performance of the SMEs it accompanies.
Show more
Investment focus
  • Manufacturing, Software, Health Care
  • Private Equity, Seed, Series A
  • France, Spain, Canada
Portfolio highlights
  • QiOVA — QiOVA offers the services in the development of dynamic laser beam shaping solution. Their ambition is to develop a sustainable and mutually profitable business with its customers through unremitting innovation and cooperation.
  • Materrup — Materrup produces low-carbon earth concrete for construction and urban development. Materrup construction solutions meet the requirements of future RE2020 regulations and the urgent need to reduce the carbon footprint of the construction industry.
  • Overseed — Overseed is an biotechnology based company which does R&D process on cannabis production for pharmaceutical purposes.
AgFunder VC Fund · San Francisco, California, United States · 15 investments in the past 12 months
AgFunder invests in impactful companies that can positively transform the world's food system. Founded in 2013, AgFunder manages a portfolio of over 50 companies across four funds from offices in Silicon Valley and Singapore. Through its media platform AFN, it has built a global ecosystem of over 90,000 subscribers.
Show more
Investment focus
  • Agriculture, AgTech, Food and Beverage
  • Seed, Series A, Pre-Seed
  • United States, United Kingdom, India
Portfolio highlights
  • Sylvarum — We improve the performance of hydroponic crops by hacking their metabolic system.
  • BioDefense — BioDefense presents Bioshield, which is made from food to protect your food, and it maximizes safety, freshness, and self-life for any fresh produce.
  • Plantik Biosciences — Plantik develops resilient crops through next-generation plant engineering technologies.
Investors by industry
Investors by country
VC Funds in France by industry